Akero Therapeutics Company
Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.
Connections from
Estimated Revenue:
$10M to $50M
Industry:
Biotechnology, Life Science, Therapeutics
Investors Number:
12
Last Funding Date:
2018
Founded Date:
2017
Investor Type:
IPO
Headquarters:
Cambridge, Massachusetts, United States
Total Funding:
135000000
Last Funding Type:
Series B
Employee Number:
11-50